Literature DB >> 32990106

Clinical features of elderly-onset Adult-onset Still's disease.

Akihito Maruyama1, Ayako Kokuzawa2, Yusuke Yamauchi3, Yohei Kirino4, Hideto Nagai4, Yasushi Inoue5, Toshiyuki Ota6, Yutaka Chifu7, Satomi Inokuchi3, Syuichi Koarada1, Akihide Ohta8, Masahiro Iwamoto2, Yoshifumi Tada1.   

Abstract

OBJECTIVES: To clarify the characteristics of patients with elderly-onset Adult-onset Still's disease (AOSD).
METHODS: Patients were classified into elderly-onset (>60 years: 47 patients) and younger-onset (≤60 years: 95 patients) groups according to their age at diagnosis of AOSD. Clinical features, treatments, and prognosis were compared between the elderly-onset and younger-onset groups.
RESULTS: In the elderly-onset group, compared with the younger-onset group, typical skin rashes were less frequent (21.3% vs 58.9%, respectively; p < .0001), whereas pleuritis (27.7% vs 7.4%, respectively; p = .0011) and disseminated intravascular coagulation (19.1% vs 2.1%, respectively; p = .0004) were more frequent, and serum ferritin levels were higher (median 12,700 ng/ml vs 2526 ng/ml, respectively; p < .0001). Overall survival and AOSD-related survival were reduced (p = .0006 and p = .0023, respectively) and drug-free remission was less frequent (p = .0035) in the elderly-onset group compared with the younger-onset group.
CONCLUSIONS: Our results demonstrated that elderly-onset AOSD patients had several characteristics that differed from younger-onset AOSD patients, including less typical skin lesions, more AOSD-related complications, higher ferritin levels, and poorer prognoses.

Entities:  

Keywords:  Adult-onset Still’s disease; complication; elderly-onset; remission

Mesh:

Year:  2020        PMID: 32990106     DOI: 10.1080/14397595.2020.1829340

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  4 in total

1.  Clinical characteristics and treatment of elderly onset adult-onset Still's disease.

Authors:  Dai Kishida; Takanori Ichikawa; Ryota Takamatsu; Shun Nomura; Masayuki Matsuda; Wataru Ishii; Tatsuo Nagai; Sadahiro Suzuki; Ken-Ichi Ueno; Naoki Tachibana; Yasuhiro Shimojima; Yoshiki Sekijima
Journal:  Sci Rep       Date:  2022-04-26       Impact factor: 4.996

2.  Associated factors with poor treatment response to initial glucocorticoid therapy in patients with adult-onset Still's disease.

Authors:  Fumiaki Kondo; Takahiko Sugihara; Natsuka Umezawa; Hisanori Hasegawa; Tadashi Hosoya; Naoki Kimura; Masaaki Mori; Shinsuke Yasuda
Journal:  Arthritis Res Ther       Date:  2022-04-29       Impact factor: 5.606

3.  Commentary: 'Case Report: A Rare Case of Elderly-Onset Adult Onset Still's Disease in a Patient With Systemic Lupus Erythematous'.

Authors:  Marion Delplanque; Arsène Mekinian; Sophie Georgin-Lavialle
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

4.  Case Report: A Rare Case of Elderly-Onset Adult-Onset Still's Disease in a Patient With Systemic Lupus Erythematosus.

Authors:  Yasuaki Hirooka; Saki Okuda; Masafumi Sugiyama; Toshihiko Shiga; Yuji Nozaki; Koji Kinoshita; Masanori Funauchi; Itaru Matsumura
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.